Novo Nordisk Aims to Invest $4.1 Billion to Expand Manufacturing Capacity in US

This $4.1 billion investment to build a second fill/finish manufacturing facility in Clayton, N.C., boosts Novo Nordisk’s current 2024 investments in production to $6.8 billion.